Qlaris Bio, Inc.

Qlaris Bio is a clinical-stage biotechnology company dedicated to developing innovative first-in-class therapies for serious and debilitating ophthalmic diseases. Their mission is to preserve vision and prevent blindness, focusing on unmet needs in glaucoma, a leading cause of preventable blindness. Qlaris Bio's lead program, QLS-111, targets episcleral venous pressure (EVP), a key contributor to intraocular pressure (IOP), which is the only modifiable risk factor for glaucoma. By targeting EVP, QLS-111 offers a potentially unique and effective approach to managing IOP and slowing disease progression, particularly for patients who have not responded well to existing therapies.

Qlaris Bio is currently conducting multiple Phase II clinical trials of QLS-111 for various forms of glaucoma, including primary open-angle glaucoma (POAG), ocular hypertension (OHT), and normal tension glaucoma (NTG). The company has a strong investor base, including Canaan, New Leaf Venture Partners, abrdn Inc., Correlation Ventures, and Mayo Clinic Ventures, demonstrating confidence in their scientific approach and the potential impact of QLS-111. If successful, QLS-111 could significantly change the treatment landscape for glaucoma, offering a new therapeutic option and potentially improving the lives of millions of patients worldwide.

Qlaris Bio is a clinical-stage biotechnology company focused on developing innovative, first-in-class therapies for serious and debilitating ophthalmic diseases, particularly glaucoma. Their mission is to preserve vision and prevent blindness by addressing unmet needs in the field of ophthalmology. Qlaris Bio believes that a multidisciplinary approach combining scientific, medical, business, and strategic considerations can lead to unique insights and unlock value for patients.

Qlaris Bio promotes a culture of innovation and collaboration, focused on developing groundbreaking therapies for ophthalmic diseases. They value a relentless commitment to scientific exploration, a comprehensive approach to problem-solving, and a strong sense of purpose to preserve vision and prevent blindness. This collaborative environment encourages diverse perspectives and a team-oriented spirit, bringing together a skilled and passionate team of individuals dedicated to achieving their mission.